FLUAD

This brand name is authorized in Austria, Canada, New Zealand, United States, South Africa

Active ingredients

The drug FLUAD contains a combination of these active pharmaceutical ingredients (APIs):

1 Influenza, inactivated, surface antigen UNII 2J002Y0B0W - INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

Read about Influenza, inactivated, surface antigen

2 Influenza, inactivated, surface antigen UNII P8ORN3UOM6 - INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

Read about Influenza, inactivated, surface antigen

3 Influenza, inactivated, surface antigen UNII INT614PB1A - INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (FORMALDEHYDE INACTIVATED)

Read about Influenza, inactivated, surface antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BB02	Influenza, purified antigen	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02362384, 02434881
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 9661
Country: US	FDA, National Drug Code	Identifier(s): 70461-020
Country: ZA	Health Products Regulatory Authority	Identifier(s): 35/30.1/0181